DottirDottir
23.irMar 12, 2026

Embosphere Microspheres

Dan Hodgin
Embosphere Microspheres
View Fullscreen

Overview

Embosphere Microspheres (Merit Medical) are biocompatible, hydrophilic, calibrated microspheres composed of tris-acryl gelatin. They are one of the most widely used particulate embolic agents in interventional radiology and are considered the gold standard for uterine artery embolisation (UAE) in the UK.

Indications

  • Uterine fibroid embolisation (UFE/UAE)

  • Hypervascular tumour embolisation (renal, hepatic, meningioma)

  • Pre-operative tumour devascularisation

  • Haemorrhage control (post-partum haemorrhage, pelvic trauma)

  • Prostatic artery embolisation (PAE)

Available Sizes

Size Range (µm)Colour CodeCommon Use
100–300PurplePAE, hypervascular tumours
300–500BlueRenal tumours, pre-op devascularisation
500–700RedUAE (most common for fibroids)
700–900YellowUAE (larger fibroids), haemorrhage
900–1200WhiteLarge vessel occlusion

Key Features

  • Calibrated and compressible — spheres are precisely sized and can compress to pass through smaller catheters, then re-expand to their calibrated size at the target site

  • Non-resorbable — provides permanent occlusion, unlike gelatin sponge

  • Hydrophilic surface — minimises catheter clogging and aggregation

  • Predictable penetration depth — calibrated sizing ensures consistent distal occlusion level

Technique Tips

  • Mix with contrast (typically 50:50 with non-ionic contrast) to create a visible slurry. Avoid mixing with saline alone as this reduces fluoroscopic visibility.

  • Inject slowly under continuous fluoroscopic observation. Stasis or reflux indicates endpoint — stop immediately.

  • For UAE, the 500–700 µm size is the workhorse. Start here unless there is a specific reason to up-size or down-size.

  • Use a 2.4–2.8 Fr microcatheter for selective embolisation. The microspheres compress through the catheter lumen.

  • Agitate the syringe regularly during injection to prevent sedimentation.

Contraindications

  • Presence of significant arteriovenous shunting (risk of non-target embolisation to the lungs)

  • Vasospasm or inability to achieve selective catheter position

  • Known allergy to gelatin-based products

References

  1. Pelage JP, Le Dref O, Beregi JP, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14(1):15-20. doi:10.1097/01.rvi.0000052287.26939.b0

Tags

Embolization
Liver
Tumor / Malignancy